This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund the development of a culturally adapted digital health application for older Hispanic patients with type 2 diabetes. The $376,208 award, granted on September 20, 2024, will be used to transform a previously developed prototype intervention into a modernized, user-friendly mobile app. The...
This Project Grant award of $731,071 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research to address barriers to equitable, guideline-recommended diabetes care in the United States. The research, led by The Johns Hopkins University, will leverage large real-world datasets and survey physicians to: 1) describe disparities in diabetes care and outcomes across individual,...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $147,459 to the University of California, Berkeley to conduct research addressing racial and ethnic disparities in diabetes risk following varying glycemia levels during pregnancy. The key objectives are to: 1) Ascertain the risk of future diabetes after gestational diabetes mellitus (GDM) and...
This federal Project Grant award of $709,563 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to leverage metabolic pathways and gene expression data to improve understanding of severe obesity in Hispanic/Latino (HL) populations, a critically understudied group. The key products and services to be delivered under this 5-year grant include: Analyzing whole blood RNA sequencing data from over...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $167,864 to The General Hospital Corporation, doing business as Massachusetts General Hospital, to conduct a mixed-methods study on adapting and developing a diabetes self-management education and support (DSMES) intervention for people with type 2 diabetes experiencing food insecurity. The key objectives of the...
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $325,000 to Kairos Research LLC, a small disadvantaged business in Dayton, OH, to develop a mobile application to help Latino adolescents manage type 1 diabetes. The key products and services to be delivered under this 1-year award include optimizing the app design through end user research and internal testing (Aim 1), as well as...
This $512,812 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports a pilot randomized trial to test the feasibility and preliminary efficacy of the T1CARE intervention. T1CARE aims to address social determinants of health for young adults with type 1 diabetes through comprehensive assessment, responsiveness, and engagement. The study will partner with a community-based...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $192,215 to The Regents of the University of California, San Francisco (UCSF) to assess patient-centric factors and enhance risk communication to improve treatment persistence for sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $614,420 to the Hennepin Healthcare Research Institute (HHRI) to test the effectiveness of the Diabetes Homeless Medication Support (D-HOMES) program on improving glycemic control among adults living with type 2 diabetes who have experienced homelessness. The D-HOMES program...
This Project Grant award of $1,573,594 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports the scaling up of the "Building Healthy Families" (BHF) childhood obesity intervention in rural and micropolitan communities across a 6-state region. The project aims to evaluate the effectiveness and implementation of the BHF online training resources and...
This $170,100 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund the development and piloting of "FUERTE: Federally Qualified Health Centers Engaging Hispanic Men at Risk of Diabetes." The goal is to create a multi-component implementation strategy to increase referrals and engagement of Hispanic men in the Diabetes Prevention Program (DPP) at Federally Qualified Health Centers (FQHCs). Key activities include conducting qualitative interviews to identify barriers, facilitating focus groups to develop user-centered content, and piloting the implementation strategy in a real-world hybrid trial at an FQHC, assessing outcomes like DPP participation, weight change, and A1C change. The award will support the career development of Dr. Christopher J. Gonzalez as an independent clinician-investigator focused on reducing racial and ethnic inequities in diabetes through implementation research.